Deerfield Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,403
Closed -$799K 453
2024
Q3
$799K Buy
7,403
+406
+6% +$44.3K 0.01% 191
2024
Q2
$759K Buy
6,997
+3,005
+75% +$354K 0.01% 189
2024
Q1
$527K Buy
3,992
+2,074
+108% +$259K 0.01% 130
2023
Q4
$233K Buy
+1,918
New +$214K ﹤0.01% 161
2021
Q3
Sell
-348,140
Closed -$54.4M 154
2021
Q2
$54.4M Sell
348,140
-19,570
-5% -$3.17M 0.97% 27
2021
Q1
$57.1M Buy
367,710
+269,860
+276% +$41.8M 1.2% 24
2020
Q4
$14.6M Buy
+97,850
New +$13.8M 0.29% 85
2018
Q4
Sell
-124,630
Closed -$15.9M 107
2018
Q3
$15.9M Hold
124,630
0.57% 54
2018
Q2
$13.5M Hold
124,630
0.47% 72
2018
Q1
$13.2M Buy
+124,630
New +$14.5M 0.46% 72
2017
Q1
Sell
-154,500
Closed -$15.5M 111
2016
Q4
$15.5M Buy
+154,500
New +$16.6M 0.64% 48

Other funds holding ZBH

Deerfield Management's ZBH Position: Q4 2024 in Review

Deerfield Management sold out of Zimmer Biomet (ZBH) in Q4 2024, closing a stake of 7,403 shares — an estimated $799K sold.

Deerfield Management first reported a position in ZBH in Q4 2016 and held it in 11 quarters. The position peaked at $57.1M in Q1 2021. 1,027 funds tracked by Wall St. Rank hold ZBH as of Q4 2024.

  • Deerfield Management reported no remaining Zimmer Biomet position as of Q4 2024 after selling out during the quarter.
  • Deerfield Management sold 7,403 Zimmer Biomet shares in Q4 2024, an estimated $799K.
  • Deerfield Management first reported a position in Zimmer Biomet in Q4 2016 and held it in 11 quarters.
  • Deerfield Management's Zimmer Biomet position peaked at $57.1M in Q1 2021.
  • 1,027 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2024.

Based on Deerfield Management's 13F filing for Q4 2024, filed 14 Feb 2025.